Proshares Ultra Nasdaq Biotechnology 2 X Shares (BIB)

Proshares Ultra Nasdaq Biotechnology 2 X Shares Stock (BIB) Forecast

The Proshares Ultra Nasdaq Biotechnology 2 X Shares (BIB) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $116.98, representing a -1.69% decrease from the current price of $119.00. The highest analyst price target is $123.43, and the lowest is $110.54.

Note: Our forecast model does not currently account for dividend and stock split events. This means that our forecast may not be accurate for stocks that have recently experienced either of these events.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.

12-Month BIB Price Target

Average 100.88 (-15.23% Downside)

Is Proshares Ultra Nasdaq Biotechnology 2 X Shares (BIB) A Buy Now?

Oscillators

Name	Value	Action
RSI(14)	52.74	Neutral
STOCH(9,6)	61.31	Neutral
STOCHRSI(14)	28.17	Neutral
MACD(12,26)	2.59	Buy
ADX(14)	15.97	Neutral
William %R	-41.93	Neutral
CCI(14)	5.00	Neutral

Buy: 1 · Sell: 0 · Neutral: 6Summary: Neutral

Moving Averages

Period	Simple	Exponential
MA10	120.03 Sell	119.63 Sell
MA20	116.49 Buy	117.45 Buy
MA50	113.68 Buy	113.97 Buy
MA100	110.01 Buy	108.49 Buy
MA200	96.47 Buy	98.14 Buy

Buy: 8 · Sell: 2 · Neutral: 0Summary: Buy

According to our latest analysis, BIB could be considered a Strong Buy, with 17 technical analysis indicators signaling 9 Buy signals, 2 signaling Sell signals and 6 Neutral signals. This might be a good time to open fresh positions on BIB, as trading bullish markets is always a lot easier

RSI (Relative Strength Index): The RSI(14) value of 52.74 indicates that BIB is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
STOCH (Stochastic Oscillator): The STOCH value of 61.31 indicates that BIB is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 28.17 indicates that BIB is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
ADX (Average Directional Index): The ADX value of 15.97 suggests that there may be some movement in price, but it lacks strength or conviction.
CCI (Commodity Channel Index): A CCI(14) value of 5.00 indicates that BIB is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.

Long-term BIB price forecast for 2026, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Proshares Ultra Nasdaq Biotechnology 2 X Shares financial reports and earnings history, Proshares Ultra Nasdaq Biotechnology 2 X Shares (BIB) stock could reach $116.68 by 2030, $199.50 by 2040 and $273.05 by 2050. See the projected annual prices until 2050 of the Proshares Ultra Nasdaq Biotechnology 2 X Shares stock below:

Proshares Ultra Nasdaq Biotechnology 2 X Shares (BIB) is expected to reach an average price of $155.73 in 2035, with a high prediction of $164.19 and a low estimate of $139.47. This indicates an +30.87% change from the last recorded price of $119.00.
Proshares Ultra Nasdaq Biotechnology 2 X Shares (BIB) stock is projected to chart a bullish course in 2040, with an average price target of $194.63, representing an +63.56% change from its current level. The forecast ranges from a conservative $173.70 to a sky-high $199.50.
Our analysts predict Proshares Ultra Nasdaq Biotechnology 2 X Shares (BIB) to change +89.42% by 2045, soaring from $217.31 to an average price of $225.41, potentially reaching $231.14. While $217.31 is the low estimate, the potential upside is significant.
Proshares Ultra Nasdaq Biotechnology 2 X Shares (BIB) stock is expected to climb by 2050, reaching an average of $267.06, a +124.42% change from its current level. However, a wide range of estimates exists, with high and low targets of $273.05 and $237.15, respectively, highlighting the market's uncertainty.

Proshares Ultra Nasdaq Biotechnology 2 X Shares Stock (BIB) Year by Year Forecast

Proshares Ultra Nasdaq Biotechnology 2 X Shares Stock (BIB) Price Forecast for 2026

The predicted value for Proshares Ultra Nasdaq Biotechnology 2 X Shares (BIB) in 2026 is set at an average of $101.17. Estimates vary from a peak of $126.40 to a trough of $73.78, indicating an -14.98% surge from the present price of $119.00.

Month	Average	Low	High	Change from today's price
December, 2026	$123.13	$110.54	$123.43	+3.47%

Proshares Ultra Nasdaq Biotechnology 2 X Shares Stock (BIB) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Proshares Ultra Nasdaq Biotechnology 2 X Shares (BIB) is $94.22, with a high forecast of $122.64 and a low forecast of $78.33. This indicates an -20.82% decrease from the last price of $119.00.

Month	Average	Low	High	Change from today's price
January, 2027	$98.21	$97.80	$122.64	-17.47%
February, 2027	$99.30	$92.93	$104.42	-16.56%
March, 2027	$92.73	$89.63	$100.41	-22.07%
April, 2027	$103.82	$91.05	$103.91	-12.75%
May, 2027	$85.12	$84.47	$106.59	-28.47%
June, 2027	$87.90	$78.89	$89.98	-26.14%
July, 2027	$91.01	$78.33	$91.11	-23.52%
August, 2027	$92.13	$87.25	$96.69	-22.58%
September, 2027	$96.37	$90.40	$102.93	-19.02%
October, 2027	$97.06	$89.43	$97.59	-18.44%
November, 2027	$90.53	$85.14	$97.60	-23.93%
December, 2027	$96.46	$88.41	$99.86	-18.94%

Proshares Ultra Nasdaq Biotechnology 2 X Shares Stock (BIB) Price Forecast for 2028

In 2028, Proshares Ultra Nasdaq Biotechnology 2 X Shares (BIB) is projected to reach an average price of $97.81, with a high projection of $105.62 and a low estimate of $90.03. This indicates an -17.81% fall from the last price of $119.00.

Month	Average	Low	High	Change from today's price
January, 2028	$105.56	$96.15	$105.62	-11.29%
February, 2028	$99.44	$96.48	$105.45	-16.44%
March, 2028	$103.98	$98.10	$105.41	-12.62%
April, 2028	$100.56	$98.20	$104.44	-15.50%
May, 2028	$93.18	$90.03	$100.37	-21.70%
June, 2028	$99.17	$91.95	$100.39	-16.66%
July, 2028	$98.27	$96.14	$100.99	-17.42%
August, 2028	$97.06	$94.18	$100.05	-18.43%
September, 2028	$92.97	$92.92	$100.62	-21.87%
October, 2028	$95.07	$92.95	$98.24	-20.11%
November, 2028	$96.31	$93.60	$97.49	-19.07%
December, 2028	$92.17	$92.17	$97.91	-22.55%

Proshares Ultra Nasdaq Biotechnology 2 X Shares Stock (BIB) Price Forecast for 2029

The 2029 price forecast for Proshares Ultra Nasdaq Biotechnology 2 X Shares Stock (BIB) is $100.72 on average, with a high prediction of $116.56 and a low estimate of $84.64. This represents an -15.36% decrease from the previous price of $119.00.

Month	Average	Low	High	Change from today's price
January, 2029	$84.83	$84.73	$93.30	-28.71%
February, 2029	$88.19	$84.64	$91.08	-25.89%
March, 2029	$92.49	$87.67	$93.35	-22.28%
April, 2029	$104.78	$92.42	$106.60	-11.95%
May, 2029	$102.51	$101.61	$105.05	-13.85%
June, 2029	$103.48	$99.78	$108.13	-13.04%
July, 2029	$103.51	$100.60	$106.37	-13.02%
August, 2029	$95.86	$93.33	$103.24	-19.45%
September, 2029	$103.48	$95.90	$104.43	-13.05%
October, 2029	$106.00	$99.73	$107.16	-10.92%
November, 2029	$112.15	$103.54	$116.01	-5.76%
December, 2029	$111.32	$104.74	$116.56	-6.46%

Proshares Ultra Nasdaq Biotechnology 2 X Shares Stock (BIB) Price Forecast for 2030

Proshares Ultra Nasdaq Biotechnology 2 X Shares Stock (BIB) is expected to reach an average price of $101.94 in 2030, with a high forecast of $116.68 and a low forecast of $83.17. This signifies an -14.34% decrease from the last price of $119.00.

Month	Average	Low	High	Change from today's price
January, 2030	$114.83	$109.00	$116.18	-3.50%
February, 2030	$109.94	$108.72	$116.68	-7.61%
March, 2030	$108.07	$108.07	$113.89	-9.18%
April, 2030	$107.73	$100.33	$116.08	-9.47%
May, 2030	$100.26	$97.86	$108.41	-15.75%
June, 2030	$99.17	$97.23	$102.29	-16.66%
July, 2030	$105.80	$99.59	$107.77	-11.09%
August, 2030	$102.07	$100.61	$106.02	-14.23%
September, 2030	$90.85	$83.17	$103.59	-23.66%
October, 2030	$89.31	$89.15	$97.59	-24.95%
November, 2030	$96.66	$89.30	$96.71	-18.77%
December, 2030	$98.54	$94.28	$98.60	-17.19%